期刊
PRENATAL DIAGNOSIS
卷 41, 期 1, 页码 145-158出版社
WILEY
DOI: 10.1002/pd.5821
关键词
-
资金
- Belgian American Educational Foundation
- Fonds Wetenschappelijk Onderzoek [1S31720N]
- Fulbright Commission Belgium
- Sofina-Boel foundation
The concept of artificial placenta and womb technology aims to provide a more physiologic approach to care for extreme premature infants by replacing placental function and establishing a womb-like environment. While past research has had limited success over the past 60 years, recent technological advancements and a focus on mimicking utero-placental physiology have improved the success of experimental models, bringing the technology closer to clinical translation.
Extreme prematurity remains a major cause of neonatal mortality and severe long-term morbidity. Current neonatal care is associated with significant morbidity due to iatrogenic injury and developmental immaturity of extreme premature infants. A more physiologic approach, replacing placental function and providing a womb-like environment, is the foundational principle of artificial placenta (AP) and womb (AW) technology. The concept has been studied during the past 60 years with limited success. However, recent technological advancements and a greater emphasis on mimicking utero-placental physiology have improved the success of experimental models, bringing the technology closer to clinical translation. Here, we review the rationale for and history of AP and AW technology, discuss the challenges that needed to be overcome, and compare recent successful models. We conclude by outlining some remaining challenges to be addressed on the path towards clinical translation and opportunities for future research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据